Search results for “Dexmedetomidine Hydrochloride” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 84 patents, we discovered top 52 key players by total patent application. Cisen Pharmaceutical Ltd., BioXcel Therapeutics, Inc., Qingdao Chenda Biotechnology Co., Ltd. are dominant in this area. They take 19.05% of the total patent filing.
Cisen Pharmaceutical Ltd.
Shandong Sheng, China
Patent: 6
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 5
Qingdao Chenda Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 5
Bio Quiddity Inc
United States
Patent: 4
Chongqing Yubeihai Technology Co., Ltd.
Chongqing Shi, China
Patent: 4
Nanjing Zenkom Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
BioQ Pharma, Inc.
California, United States
Patent: 3
Nanjing Yihua Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
CSPC Yinhu Pharmaceutical Co., Ltd.
Shanxi Sheng, China
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 43 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing BioXcel Therapeutics, Inc., Nanjing Yihua Pharmaceutical Co. Ltd., Tianjin Pharmaceutical Group Xinzheng Co. Ltd. take 23.26% of patent filing during this period.
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 5
Nanjing Yihua Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Tianjin Pharmaceutical Group Xinzheng Co. Ltd.
Henan Sheng, China
Patent: 2
Ningbo Mengman Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Nanjing Zenkom Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Hunan Kangpu Pharmaceutical Co. Ltd.
Hunan Sheng, China
Patent: 2
Cisen Pharmaceutical Ltd.
Shandong Sheng, China
Patent: 2
Jilin Huikang Pharmaceutical Co Ltd
Jilin Sheng, China
Patent: 1
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 43 patents in last 5 years, we discover 28 new entrants. BioXcel Therapeutics, Inc., Nanjing Yihua Pharmaceutical Co. Ltd., Tianjin Pharmaceutical Group Xinzheng Co. Ltd. are the most active new entrants in this area.
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 5
Nanjing Yihua Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Tianjin Pharmaceutical Group Xinzheng Co. Ltd.
Henan Sheng, China
Patent: 2
Ningbo Mengman Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 2
Hunan Kangpu Pharmaceutical Co. Ltd.
Hunan Sheng, China
Patent: 2
Jilin Huikang Pharmaceutical Co Ltd
Jilin Sheng, China
Patent: 1
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
KriSan Biotech Co., Ltd.
Taiwan Province, China
Patent: 1
Affiliated Hospital of Jiangsu University
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 universities and scientific research institutions by total patent application.
Wuhan University
Hubei Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: